paclitaxel has been researched along with Common Bile Duct Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, CP; Hu, JJ; Miao, X; Tang, H; Xu, H; Zhang, H; Zhou, WC | 1 |
| Bai, LY; Chen, CY; Chiu, CF | 1 |
| Frank, H; Kitzwögerer, M; Moser, M; Wiedemann, D | 1 |
| Abbruzzese, JL; Crane, CH; Evans, DB; Hudec, WA; Janjan, NA; Lahoti, S; Lee, JE; Lenzi, R; Pisters, PW; Raijman, I; Rich, TA; Wolff, RA | 1 |
4 other study(ies) available for paclitaxel and Common Bile Duct Neoplasms
| Article | Year |
|---|---|
Establishment and characterization of a new human ampullary carcinoma cell line, DPC-X1.
Topics: Ampulla of Vater; Animals; Carcinoembryonic Antigen; Cell Line; Cell Line, Tumor; Common Bile Duct Neoplasms; Fluorouracil; Humans; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Mice, Nude; Oxaliplatin; Paclitaxel | 2023 |
Treatment of pembrolizumab-induced cutaneous lesions with ruxolitinib.
Topics: Adenocarcinoma; Aged; Ampulla of Vater; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arm; Common Bile Duct Neoplasms; Drug Eruptions; Glucocorticoids; Histamine Antagonists; Humans; Janus Kinase Inhibitors; Liver Neoplasms; Male; Nitriles; Paclitaxel; Prednisolone; Pyrazoles; Pyrimidines; Scrotum; Thigh; Torso | 2019 |
Adenocarcinoma of the ampulla of Vater metastasising into the right ventricle.
Topics: Adenocarcinoma; Adult; Albumins; Ampulla of Vater; Chemotherapy, Adjuvant; Common Bile Duct Neoplasms; Deoxycytidine; Female; Gemcitabine; Heart Neoplasms; Heart Ventricles; Humans; Neoplasm Recurrence, Local; Paclitaxel | 2016 |
Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Common Bile Duct Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Hospitalization; Humans; Incidence; Liver; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pancreatic Neoplasms; Pancreaticoduodenectomy; Radiotherapy Dosage; Retrospective Studies; Stents | 2000 |